Corporate Profile

Webcast ImageWebcast
Q2 2015 Teleflex Incorporated Earnings Conference Call (Replay)
07/30/15 at 8:00 a.m. ET
Q2 2015 Teleflex Incorporated Earnings Conference Call
Thursday, July 30, 2015 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
Recent NewsMore »
Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--Jul. 30, 2015-- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 14, 2015 to shareholders of record at the close of business on August 14, 2015. Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and s... 
Teleflex Reports Second Quarter 2015 Results
Second Quarter Revenues of $452.1 million, down 3.4% over prior year period; up 4.7% on Constant Currency Basis Second Quarter GAAP Diluted EPS of $0.93, down 10.6% over the prior year period Second Quarter Adjusted Diluted EPS of $1.42, down 6.0%, reflecting unfavorable impact from foreign exchange of approximately 20% 2015 Constant Currency Revenue and Adjusted Diluted EPS Guidance Reaffirmed WAYNE, Pa.--(BUSIN... 
Teleflex Signs New Agreement With HealthTrust For Port Closure Products
WAYNE, Pa.--(BUSINESS WIRE)--Jul. 29, 2015-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced a new group purchasing agreement with HealthTrust covering Teleflex Incorporated’s Weck EFx® Portfolio of Port Closure products. The agreement becomes effective August 1, 2015. Weck EFx Port Closure Products from Teleflex are designed to allow surgeons to provide fast, saf... 
ARROW Endurance™ Extended Dwell Peripheral Catheter System Receives FDA Market Clearance
Catheter System Designed to Provide Peripheral Vascular Access “When a PIV is Not Enough and a PICC is Too Much” WAYNE, Pa.--(BUSINESS WIRE)--Jul. 29, 2015-- Teleflex Incorporated (NYSE:TFX), a global provider of medical devices for critical care and surgery, announced today that its ARROW Endurance™ Extended Dwell Peripheral Catheter System received market clearance from the U.S. Food and Drug Administration (FDA). The new dev... 
Upcoming EventsMore »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet